U.S. Food and Drug Administration grants rapid approval to Tec-Dara, a combination of teclistamab and daratumumab hyaluronidase-fihj, for adults with relapsed or refractory multiple myeloma after at least one prior therapy.
Janssen Biotech | 07/03/2026 | By News Bureau
Ailux Biologics Forges License Deal with Janssen Biotech on Biologics AI Platform
Under the agreement, Ailux Biologics grants Janssen and its affiliates a non-exclusive license to leverage its XtalFold platform for the discovery and engineering of biologics.
Janssen Biotech | 14/10/2024 | By Aishwarya | 274
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy